title: Intracellular MMP-2 activity in skeletal muscle is associated with type II fibers.
abstract: Matrix metalloproteinase 2 (MMP-2) is a proteolytic enzyme implicated in motility, differentiation, and regeneration of skeletal muscle fibers through processing of extracellular substrates. Although MMP-2 has been found to be localized intracellularly in cardiomyocytes where the enzyme is thought to contribute to post-ischemic loss of contractility, little is known about intracellular MMP-2 activity in skeletal muscle fibers. In the present study we demonstrate intracellular MMP-2 in normal skeletal muscle by immunohistochemical staining. Immunogold electron microscopic analyses indicated that the enzyme was concentrated in Z-lines of the sarcomers, in the nuclear membrane, and in mitochondria. By use of in situ zymography, we found that gelatinolytic activity in muscle fibers was co-localized with immunofluorecent staining for MMP-2. Staining for MMP-9, the other member of the gelatinase group of the MMPs, was negative. The broad-spectrum metalloprotease inhibitor EDTA and the selective gelatinase inhibitor CTT2, but not the cysteine inhibitor E64, strongly reduced the gelatinolytic activity. The intracellular gelatinolytic activity was much more prominent in fast twitch type II fibers than in slow twitch type I fibers, and there was a decrease in intracellular gelatinolytic activity and MMP-2 expression in muscles from mice exposed to high intensity interval training. Together our results indicate that MMP-2 is part of the intracellular proteolytic network in normal skeletal muscle, especially in fast twitch type II fibers. Further, the results suggest that intracellular MMP-2 in skeletal muscle fibers is active during normal homeostasis, and affected by the level of physical activity.
authors.affiliation: Department of Medical Biology, Faculty of Health Sciences, University of Tromsø, Tromsø, Norway.
authors.forename: Elin
authors.initials: E
authors.lastname: Hadler-Olsen
authors.forename: Ann Iren
authors.initials: AI
authors.lastname: Solli
authors.forename: Anne
authors.initials: A
authors.lastname: Hafstad
authors.forename: Jan-Olof
authors.initials: JO
authors.lastname: Winberg
authors.forename: Lars
authors.initials: L
authors.lastname: Uhlin-Hansen
mesh_terms: D000818:Animals; D002454:Cell Differentiation; D002460:Cell Line; D015853:Cysteine Proteinase Inhibitors / Q000494:pharmacology; D004492:Edetic Acid / Q000494:pharmacology; D018093:Gelatinases / Q000037:antagonists & inhibitors; D007930:Leucine / Q000031:analogs & derivatives / Q000494:pharmacology; D008297:Male; D020778:Matrix Metalloproteinase 2 / Q000096:biosynthesis / Q000378:metabolism*; D051379:Mice; D008810:Mice, Inbred C57BL; D032342:Muscle Cells / Q000166:cytology; D018656:Muscle Fibers, Fast-Twitch / Q000201:enzymology*; D018657:Muscle Fibers, Slow-Twitch / Q000201:enzymology*; D032446:Myoblasts / Q000166:cytology; D010456:Peptides, Cyclic / Q000494:pharmacology; D010805:Physical Conditioning, Animal; D012518:Sarcomeres / Q000378:metabolism
chemical_list: D015853:Cysteine Proteinase Inhibitors; C509825:GRENYHGCTTHWGFTLC peptide; D010456:Peptides, Cyclic; D004492:Edetic Acid; D018093:Gelatinases; D020778:Matrix Metalloproteinase 2; D007930:Leucine; C024974:E 64